Nothing Special   »   [go: up one dir, main page]

Golledge et al., 2011 - Google Patents

The role of tenascin C in cardiovascular disease

Golledge et al., 2011

View HTML
Document ID
10908774288440981448
Author
Golledge J
Clancy P
Maguire J
Lincz L
Koblar S
Publication year
Publication venue
Cardiovascular research

External Links

Snippet

The extracellular matrix protein tenascin C (TnC) is expressed in a variety of embryonic tissues, but its expression in adult arteries is co-incident with sites of vascular disease. TnC expression has been linked to the development and complications of intimal hyperplasia …
Continue reading at academic.oup.com (HTML) (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Similar Documents

Publication Publication Date Title
Golledge et al. The role of tenascin C in cardiovascular disease
Osmanagic-Myers et al. Endothelial progerin expression causes cardiovascular pathology through an impaired mechanoresponse
Brisset et al. Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro
Wallner et al. Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque
Inamoto et al. TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections
Tsai et al. TGF-β through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation
Zachary et al. Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family
Maurage et al. Endocan expression and localization in human glioblastomas
Sugano et al. Granulocyte colony-stimulating factor attenuates early ventricular expansion after experimental myocardial infarction
Italiano Jr et al. Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet α granules and differentially released
Bujak et al. The role of TGF-β signaling in myocardial infarction and cardiac remodeling
Kudo et al. Venous identity is lost but arterial identity is not gained during vein graft adaptation
Okamoto et al. Matricellular proteins: new molecular targets to prevent heart failure
Merrilees et al. Retrovirally mediated overexpression of versican v3 by arterial smooth muscle cells induces tropoelastin synthesis and elastic fiber formation in vitro and in neointima after vascular injury
Masoud et al. Apelin directs endothelial cell differentiation and vascular repair following immune-mediated injury
Krishna et al. The role of thrombospondin-1 in cardiovascular health and pathology
Hahn et al. The role of cellular adaptation to mechanical forces in atherosclerosis
Chen et al. Cathepsin S-mediated fibroblast trans-differentiation contributes to left ventricular remodelling after myocardial infarction
Herum et al. Syndecan‐4 protects the heart from the profibrotic effects of thrombin‐cleaved osteopontin
Sartore et al. Myosin gene expression and cell phenotypes in vascular smooth muscle during development, in experimental models, and in vascular disease
Morrison et al. Chemokine-coupled β2 integrin–induced macrophage Rac2–Myosin IIA interaction regulates VEGF-A mRNA stability and arteriogenesis
Liu et al. CCN4 regulates vascular smooth muscle cell migration and proliferation
Di Benedetto et al. Endothelial-to-mesenchymal transition in systemic sclerosis
Otsuka et al. Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1–dependent pathways
Myers et al. Alterations of arterial physiology in osteopontin-null mice